Skip to main content
Skip to main content
  • Overview
    • News
    • Events & Presentations
      • Events Calendar
      • Presentations
    • Stock Info
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
      • October 11, 2023
        Reorganization Merger
        Form 8937
Ambrx
Site Search
  • Overview
    • News
    • Events & Presentations
      • Events Calendar
      • Presentations
    • Stock Info
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
      • October 11, 2023
        Reorganization Merger
        Form 8937

News Details

  • Overview
    • News
    • Events & Presentations
      • Events Calendar
      • Presentations
    • Stock Info
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Governance Documents
      • Executive Management
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
      • October 11, 2023
        Reorganization Merger
        Form 8937
View All News

ESMO 2023 Posters and ARX517 Slide Deck Available Here

10/21/2023
ESMO 2023 APEX-01 Slide Deck (opens in new window)
ESMO 2023 ARX517 Clinical Poster (opens in new window)
ESMO 2023 ARX517 PK Poster (opens in new window)
ESMO 2023 ARX517 Preclinical Poster (opens in new window)
ESMO 2023 ARX305 Preclinical Poster (opens in new window)
View All News
Ambrx

Quick Links

  • SEC Filings
  • Investor FAQs

Contact Us

IR:

investor-relations@its.jnj.com

Media:

media-relations@its.jnj.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Ambrx, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Ambrx to send you the requested Investor Email Alert updates.

* Required

*
*





Unsubscribe

Email Alert Sign Up Confirmation

Copyright © 2022 Ambrx. All Rights Reserved | Privacy | Site Map | Terms of Use

Powered By Q4 Inc. 5.155.1.2 (opens in new window)